30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

WAVE Life Sciences Ltd (WVE)

Track

In the last 90 days, WAVE Life Sciences Ltd. saw significant insider buying totaling over $54.6 million, primarily from RA CAPITAL MANAGEMENT, L.P. This contrasts with a smaller volume of sales by other insiders. The company's stock has experienced a notable decline of over 52% in the past 90 days.
Stock chart
Ticker: WVE Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
RA CAPITAL MANAGEMENT, L.P.
1 purchase — total 6,312,092 USD
Buy 30 Mar 2026
Value US$1,768,647.96 | Price 12.85 | Shares 20,170
Buy 27 Mar 2026
Value US$2,789,149.47 | Price 438.97 | Shares 88,639
Buy 26 Mar 2026
Value US$2,240,809.12 | Price 6.38 | Shares 351,224
Buy 26 Mar 2026
Value US$30,024,621.48 | Price 6.06 | Shares 4,954,558
Planned sale 26 Feb 2026
Value US$229,410.00 | Price 15.00 | Shares 15,294
Planned sale 26 Feb 2026
Value US$270,182.60 | Price 15.09 | Shares 17,900
Sale 9 Feb 2026
Value US$140,956.00 | Price 13.45 | Shares 10,480
Sale 9 Feb 2026
Value US$25,326.35 | Price 13.45 | Shares 1,883
Sale 9 Feb 2026
Value US$43,416.60 | Price 13.45 | Shares 3,228
Sale 9 Feb 2026
Value US$48,258.60 | Price 13.45 | Shares 3,588
Proposed sale 9 Feb 2026
Value US$47,935.80 | Price 13.45 | Shares 3,564
Proposed sale 9 Feb 2026
Value US$140,027.95 | Price 13.45 | Shares 10,411
Proposed sale 9 Feb 2026
Value US$25,151.50 | Price 13.45 | Shares 1,870
Planned sale 2 Jan 2026
Value US$21,626.50 | Price 16.70 | Shares 1,295
Planned sale 2 Jan 2026
Value US$128,633.60 | Price 15.92 | Shares 8,080
Buy 11 Dec 2025
Value US$27,930,000.00 | Price 19.00 | Shares 1,470,000
Planned sale 9 Dec 2025
Value US$1,001,250.00 | Price 20.03 | Shares 50,000
Planned sale 9 Dec 2025
Value US$729.00 | Price 20.25 | Shares 36
Proposed sale 9 Dec 2025
Value US$1,592,720.00 | Price 18.52 | Shares 86,000
Planned sale 8 Dec 2025
Value US$98,000.00 | Price 14.00 | Shares 7,000
Planned sale 8 Dec 2025
Value US$91,000.00 | Price 13.00 | Shares 7,000
Planned sale 8 Dec 2025
Value US$112,119.00 | Price 14.05 | Shares 7,980
Planned sale 8 Dec 2025
Value US$157,341.80 | Price 13.09 | Shares 12,020
Planned sale 8 Dec 2025
Value US$900,000.00 | Price 18.00 | Shares 50,000
Planned sale 8 Dec 2025
Value US$660,000.00 | Price 13.20 | Shares 50,000
Planned sale 8 Dec 2025
Value US$750,000.00 | Price 15.00 | Shares 50,000
Planned sale 8 Dec 2025
Value US$792,000.00 | Price 13.20 | Shares 60,000
Planned sale 8 Dec 2025
Value US$540,600.00 | Price 18.02 | Shares 30,000
Planned sale 8 Dec 2025
Value US$211,050.00 | Price 14.07 | Shares 15,000
Planned sale 8 Dec 2025
Value US$535,500.00 | Price 12.75 | Shares 42,000
Planned sale 8 Dec 2025
Value US$82,173.75 | Price 12.75 | Shares 6,445
Planned sale 8 Dec 2025
Value US$91,633.47 | Price 14.07 | Shares 6,515
Planned sale 8 Dec 2025
Value US$125,664.00 | Price 13.09 | Shares 9,600
Planned sale 8 Dec 2025
Value US$630,000.00 | Price 15.00 | Shares 42,000
Planned sale 8 Dec 2025
Value US$316,800.00 | Price 14.08 | Shares 22,500
Planned sale 8 Dec 2025
Value US$800,000.00 | Price 16.00 | Shares 50,000
Planned sale 8 Dec 2025
Value US$1,736,744.06 | Price 14.20 | Shares 122,349
Planned sale 8 Dec 2025
Value US$268,500.00 | Price 15.00 | Shares 17,900
Planned sale 8 Dec 2025
Value US$528,000.00 | Price 14.08 | Shares 37,500
Planned sale 8 Dec 2025
Value US$140,625.00 | Price 15.00 | Shares 9,375
Planned sale 8 Dec 2025
Value US$665,289.00 | Price 14.50 | Shares 45,882
Planned sale 8 Dec 2025
Value US$1,563,314.40 | Price 14.56 | Shares 107,400
Planned sale 8 Dec 2025
Value US$407,812.50 | Price 14.50 | Shares 28,125
Planned sale 8 Dec 2025
Value US$267,750.00 | Price 12.75 | Shares 21,000
Planned sale 8 Dec 2025
Value US$267,750.00 | Price 12.75 | Shares 21,000
Planned sale 8 Dec 2025
Value US$375,000.00 | Price 15.00 | Shares 25,000
Planned sale 8 Dec 2025
Value US$255,000.00 | Price 12.75 | Shares 20,000
Planned sale 8 Dec 2025
Value US$258,450.00 | Price 15.00 | Shares 17,230
Planned sale 8 Dec 2025
Value US$191,250.00 | Price 12.75 | Shares 15,000
Planned sale 8 Dec 2025
Value US$112,410.00 | Price 15.00 | Shares 7,494
Planned sale 8 Dec 2025
Value US$95,548.50 | Price 12.75 | Shares 7,494
Proposed sale 8 Dec 2025
Value US$1,730,601.00 | Price 18.52 | Shares 93,445
Proposed sale 8 Dec 2025
Value US$104,860.00 | Price 7.49 | Shares 14,000
Proposed sale 8 Dec 2025
Value US$1,572,900.00 | Price 7.49 | Shares 210,000
Proposed sale 8 Dec 2025
Value US$3,622,178.98 | Price 7.49 | Shares 483,602
Proposed sale 8 Dec 2025
Value US$149,800.00 | Price 7.49 | Shares 20,000
Proposed sale 8 Dec 2025
Value US$314,580.00 | Price 7.49 | Shares 42,000
Proposed sale 8 Dec 2025
Value US$120,701.35 | Price 7.49 | Shares 16,115
Proposed sale 8 Dec 2025
Value US$1,823,158.50 | Price 13.58 | Shares 134,218
Planned sale 13 Nov 2025
Value US$109,420.85 | Price 6.79 | Shares 16,115
Buy 13 Nov 2025
Value US$6,687.50 | Price 6.69 | Shares 1,000
Proposed sale 13 Nov 2025
Value US$112,079.83 | Price 6.96 | Shares 16,115
Planned sale 22 Aug 2025
Value US$100,000.00 | Price 10.00 | Shares 10,000
Planned sale 22 Aug 2025
Value US$2,194,810.40 | Price 10.10 | Shares 217,351
Proposed sale 22 Aug 2025
Value US$2,121,345.76 | Price 9.76 | Shares 217,351
Proposed sale 22 Aug 2025
Value US$244,000.00 | Price 9.76 | Shares 25,000
Planned sale 15 Aug 2025
Value US$194,250.00 | Price 9.25 | Shares 21,000
Proposed sale 15 Aug 2025
Value US$194,250.00 | Price 9.25 | Shares 21,000
Proposed sale 13 Aug 2025
Value US$74,459.00 | Price 7.70 | Shares 9,670
Planned sale 13 Aug 2025
Value US$85,192.70 | Price 8.81 | Shares 9,670
Planned sale 5 Aug 2025
Value US$9,861.25 | Price 8.75 | Shares 1,127
Planned sale 5 Aug 2025
Value US$42,630.00 | Price 8.75 | Shares 4,872
Proposed sale 13 Jun 2025
Value US$216,000.00 | Price 7.20 | Shares 30,000
Planned sale 13 Jun 2025
Value US$208,500.00 | Price 6.95 | Shares 30,000
Planned sale 20 Mar 2025
Value US$102,574.50 | Price 9.77 | Shares 10,500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-30 2026-03-30 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
20,170 +33.2%
12.85
US$1,768,648 		20,170 +33.2% 12.85 US$1,768,648
2026-03-30 2026-03-27 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
88,639 -9.3%
438.97
US$2,789,149 		88,639 -9.3% 438.97 US$2,789,149
2026-03-30 2026-03-26 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
29,227 +22.6%
367.54
US$3,152,905 		29,227 +22.6% 367.54 US$3,152,905
2026-03-30 2026-03-26 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
4,954,558 +27.2%
6.06
US$30,024,621 		4,954,558 +27.2% 6.06 US$30,024,621
2026-02-27 2026-02-26 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
15,294 -19.8%
15.00
US$229,410 		15,294 -19.8% 15.00 US$229,410
2026-02-27 2026-02-26 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
17,900 -22.4%
15.09
US$270,183 		17,900 -22.4% 15.09 US$270,183
2026-02-11 2026-02-09 S Sale
3.2
BOLNO PAUL

President and CEO

Executive Director
10,480 -3.7%
13.45
US$140,956 		10,480 -3.7% 13.45 US$140,956
2026-02-11 2026-02-09 S Sale
3.2
Francis Chris

See Remarks

Officer
1,883 -3.0%
13.45
US$25,326 		1,883 -3.0% 13.45 US$25,326
2026-02-11 2026-02-09 S Sale
3.2
Vargeese Chandra

See Remarks

Officer
3,228 -0.8%
13.45
US$43,417 		3,228 -0.8% 13.45 US$43,417
2026-02-11 2026-02-09 S Sale
3.2
Moran Kyle

Chief Financial Officer

Officer
3,588 -2.6%
13.45
US$48,259 		3,588 -2.6% 13.45 US$48,259
2026-02-09 2026-02-09 PrS Proposed sale
3.2
KYLE MORAN

Officer

Officer
3,564
13.45
US$47,936 		3,564 13.45 US$47,936
2026-02-09 2026-02-09 PrS Proposed sale
3.2
PAUL BOLNO

Officer

Officer
10,411
13.45
US$140,028 		10,411 13.45 US$140,028
2026-02-09 2026-02-09 PrS Proposed sale
3.2
Chris Francis

Officer

Officer
1,870
13.45
US$25,152 		1,870 13.45 US$25,152
2026-01-06 2026-01-02 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
1,295 -4.9%
16.70
US$21,626 		1,295 -4.9% 16.70 US$21,626
2026-01-06 2026-01-02 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
8,080 -23.5%
15.92
US$128,634 		8,080 -23.5% 15.92 US$128,634
2025-12-15 2025-12-11 B Purchase
2.3
GSK plc
Large shareholder
1,470,000 +8.8%
19.00
US$27,930,000 		1,470,000 +8.8% 19.00 US$27,930,000
2025-12-10 2025-12-09 PlS Planned sale
3.2
Moran Kyle

Chief Financial Officer

Officer
50,000 -35.6%
20.03
US$1,001,250 		50,000 -35.6% 20.03 US$1,001,250
2025-12-10 2025-12-09 PlS Planned sale
3.2
Moran Kyle

Chief Financial Officer

Officer
36 -0.0%
20.25
US$729 		36 -0.0% 20.25 US$729
2025-12-09 2025-12-09 PrS Proposed sale
3.2
KYLE MORAN

Officer

Officer
86,000
18.52
US$1,592,720 		86,000 18.52 US$1,592,720
2025-12-10 2025-12-08 PlS Planned sale
Wagner Heidi L
Non-Executive Director
7,000 -13.5%
14.00
US$98,000 		7,000 -13.5% 14.00 US$98,000
2025-12-10 2025-12-08 PlS Planned sale
Wagner Heidi L
Non-Executive Director
7,000 -13.5%
13.00
US$91,000 		7,000 -13.5% 13.00 US$91,000
2025-12-10 2025-12-08 PlS Planned sale
Verdine Gregory L.
Non-Executive Director
7,980 -2.8%
14.05
US$112,119 		7,980 -2.8% 14.05 US$112,119
2025-12-10 2025-12-08 PlS Planned sale
Verdine Gregory L.
Non-Executive Director
12,020 -4.1%
13.09
US$157,342 		12,020 -4.1% 13.09 US$157,342
2025-12-10 2025-12-08 PlS Planned sale
3.2
Moran Kyle

Chief Financial Officer

Officer
50,000 -35.9%
18.00
US$900,000 		50,000 -35.9% 18.00 US$900,000
2025-12-10 2025-12-08 PlS Planned sale
3.2
Moran Kyle

Chief Financial Officer

Officer
50,000 -35.9%
13.20
US$660,000 		50,000 -35.9% 13.20 US$660,000
2025-12-10 2025-12-08 PlS Planned sale
3.2
Moran Kyle

Chief Financial Officer

Officer
50,000 -26.4%
15.00
US$750,000 		50,000 -26.4% 15.00 US$750,000
2025-12-10 2025-12-08 PlS Planned sale
3.2
Moran Kyle

Chief Financial Officer

Officer
60,000 -40.2%
13.20
US$792,000 		60,000 -40.2% 13.20 US$792,000
2025-12-10 2025-12-08 PlS Planned sale
4.1
HENRY CHRISTIAN O
Non-Executive Director
30,000 -70.3%
18.02
US$540,600 		30,000 -70.3% 18.02 US$540,600
2025-12-10 2025-12-08 PlS Planned sale
4.1
HENRY CHRISTIAN O
Non-Executive Director
15,000 -54.2%
14.07
US$211,050 		15,000 -54.2% 14.07 US$211,050
2025-12-10 2025-12-08 PlS Planned sale
4.1
HENRY CHRISTIAN O
Non-Executive Director
42,000 -76.8%
12.75
US$535,500 		42,000 -76.8% 12.75 US$535,500
2025-12-10 2025-12-08 PlS Planned sale
4.1
HENRY CHRISTIAN O
Non-Executive Director
6,445 -33.7%
12.75
US$82,174 		6,445 -33.7% 12.75 US$82,174
2025-12-10 2025-12-08 PlS Planned sale
3.3
CORRIGAN MARK
Non-Executive Director
6,515 -18.4%
14.07
US$91,633 		6,515 -18.4% 14.07 US$91,633
2025-12-10 2025-12-08 PlS Planned sale
3.3
CORRIGAN MARK
Non-Executive Director
9,600 -21.4%
13.09
US$125,664 		9,600 -21.4% 13.09 US$125,664
2025-12-10 2025-12-08 PlS Planned sale
3.0
Rawcliffe Adrian
Non-Executive Director
42,000 -76.8%
15.00
US$630,000 		42,000 -76.8% 15.00 US$630,000
2025-12-10 2025-12-08 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
22,500 -47.4%
14.08
US$316,800 		22,500 -47.4% 14.08 US$316,800
2025-12-10 2025-12-08 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
50,000 -66.7%
16.00
US$800,000 		50,000 -66.7% 16.00 US$800,000
2025-12-10 2025-12-08 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
122,349 -83.0%
14.20
US$1,736,744 		122,349 -83.0% 14.20 US$1,736,744
2025-12-10 2025-12-08 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
17,900 -41.7%
15.00
US$268,500 		17,900 -41.7% 15.00 US$268,500
2025-12-10 2025-12-08 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
37,500 -60.0%
14.08
US$528,000 		37,500 -60.0% 14.08 US$528,000
2025-12-10 2025-12-08 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
9,375 -27.3%
15.00
US$140,625 		9,375 -27.3% 15.00 US$140,625
2025-12-10 2025-12-08 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
45,882 -64.7%
14.50
US$665,289 		45,882 -64.7% 14.50 US$665,289
2025-12-10 2025-12-08 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
107,400 -81.1%
14.56
US$1,563,314 		107,400 -81.1% 14.56 US$1,563,314
2025-12-10 2025-12-08 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
28,125 -52.9%
14.50
US$407,812 		28,125 -52.9% 14.50 US$407,812
2025-12-10 2025-12-08 PlS Planned sale
Tan Aik Na
Non-Executive Director
21,000 -45.3%
12.75
US$267,750 		21,000 -45.3% 12.75 US$267,750
2025-12-10 2025-12-08 PlS Planned sale
Tan Aik Na
Non-Executive Director
21,000 -45.3%
12.75
US$267,750 		21,000 -45.3% 12.75 US$267,750
2025-12-10 2025-12-08 PlS Planned sale
Tan Aik Na
Non-Executive Director
25,000 -49.6%
15.00
US$375,000 		25,000 -49.6% 15.00 US$375,000
2025-12-10 2025-12-08 PlS Planned sale
Tan Aik Na
Non-Executive Director
20,000 -28.4%
12.75
US$255,000 		20,000 -28.4% 12.75 US$255,000
2025-12-10 2025-12-08 PlS Planned sale
Tan Aik Na
Non-Executive Director
17,230 -40.4%
15.00
US$258,450 		17,230 -40.4% 15.00 US$258,450
2025-12-10 2025-12-08 PlS Planned sale
Tan Aik Na
Non-Executive Director
15,000 -26.0%
12.75
US$191,250 		15,000 -26.0% 12.75 US$191,250
2025-12-10 2025-12-08 PlS Planned sale
Tan Aik Na
Non-Executive Director
7,494 -22.8%
15.00
US$112,410 		7,494 -22.8% 15.00 US$112,410
2025-12-10 2025-12-08 PlS Planned sale
Tan Aik Na
Non-Executive Director
7,494 -18.6%
12.75
US$95,548 		7,494 -18.6% 12.75 US$95,548
2025-12-08 2025-12-08 PrS Proposed sale
4.1
Henry Family Trust

Affiliate
93,445
18.52
US$1,730,601 		93,445 18.52 US$1,730,601
2025-12-08 2025-12-08 PrS Proposed sale
HEIDI L WAGNER

Director

Non-Executive Director
14,000
7.49
US$104,860 		14,000 7.49 US$104,860
2025-12-08 2025-12-08 PrS Proposed sale
3.2
KYLE MORAN

Officer

Officer
210,000
7.49
US$1,572,900 		210,000 7.49 US$1,572,900
2025-12-08 2025-12-08 PrS Proposed sale
3.2
CHRISTOPHER FRANCIS

Officer

Officer
483,602
7.49
US$3,622,179 		483,602 7.49 US$3,622,179
2025-12-08 2025-12-08 PrS Proposed sale
GREGORY VERDINE

Director

Non-Executive Director
20,000
7.49
US$149,800 		20,000 7.49 US$149,800
2025-12-08 2025-12-08 PrS Proposed sale
3.0
ADRIAN RAWCLIFFE

Director

Non-Executive Director
42,000
7.49
US$314,580 		42,000 7.49 US$314,580
2025-12-08 2025-12-08 PrS Proposed sale
3.3
MARK CORRIGAN

Director

Non-Executive Director
16,115
7.49
US$120,701 		16,115 7.49 US$120,701
2025-12-08 2025-12-08 PrS Proposed sale
AIK NA TAN

Director

Non-Executive Director
134,218
13.58
US$1,823,158 		134,218 13.58 US$1,823,158
2025-11-14 2025-11-13 PlS Planned sale
3.0
Rawcliffe Adrian
Non-Executive Director
16,115 -55.9%
6.79
US$109,421 		16,115 -55.9% 6.79 US$109,421
2025-11-14 2025-11-13 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
1,000 +0.0%
6.69
US$6,688 		1,000 +0.0% 6.69 US$6,688
2025-11-13 2025-11-13 PrS Proposed sale
3.0
ADRIAN RAWCLIFFE

Director

Non-Executive Director
16,115
6.96
US$112,080 		16,115 6.96 US$112,080
2025-08-26 2025-08-22 PlS Planned sale
Verdine Gregory L.
Non-Executive Director
10,000 -3.4%
10.00
US$100,000 		10,000 -3.4% 10.00 US$100,000
2025-08-26 2025-08-22 PlS Planned sale
3.2
BOLNO PAUL

President and CEO

Executive Director
217,351 -64.2%
10.10
US$2,194,810 		217,351 -64.2% 10.10 US$2,194,810
2025-08-22 2025-08-22 PrS Proposed sale
3.2
PAUL BOLNO

Director; Officer

Executive Director
217,351
9.76
US$2,121,346 		217,351 9.76 US$2,121,346
2025-08-22 2025-08-22 PrS Proposed sale
GREGORY VERDINE

Director

Non-Executive Director
25,000
9.76
US$244,000 		25,000 9.76 US$244,000
2025-08-19 2025-08-15 PlS Planned sale
Tan Aik Na
Non-Executive Director
21,000 -34.2%
9.25
US$194,250 		21,000 -34.2% 9.25 US$194,250
2025-08-15 2025-08-15 PrS Proposed sale
AIK NA TAN

Director

Non-Executive Director
21,000
9.25
US$194,250 		21,000 9.25 US$194,250
2025-08-13 2025-08-13 PrS Proposed sale
4.1
Christian Henry

Director

Non-Executive Director
9,670
7.70
US$74,459 		9,670 7.70 US$74,459
2025-08-13 2025-08-13 PlS Planned sale
4.1
HENRY CHRISTIAN O
Non-Executive Director
9,670 -24.6%
8.81
US$85,193 		9,670 -24.6% 8.81 US$85,193
2025-08-07 2025-08-05 PlS Planned sale
Tan Aik Na
Non-Executive Director
1,127 -7.0%
8.75
US$9,861 		1,127 -7.0% 8.75 US$9,861
2025-08-07 2025-08-05 PlS Planned sale
1.4
TAKANASHI KEN
Non-Executive Director
4,872 -0.1%
8.75
US$42,630 		4,872 -0.1% 8.75 US$42,630
2025-06-13 2025-06-13 PrS Proposed sale
GREGORY VERDINE

Director

Non-Executive Director
30,000
7.20
US$216,000 		30,000 7.20 US$216,000
2025-06-13 2025-06-13 PlS Planned sale
Verdine Gregory L.
Non-Executive Director
30,000 -9.6%
6.95
US$208,500 		30,000 -9.6% 6.95 US$208,500
2025-03-21 2025-03-20 PlS Planned sale
4.1
HENRY CHRISTIAN O
Non-Executive Director
10,500 -39.5%
9.77
US$102,574 		10,500 -39.5% 9.77 US$102,574
Explore more

More insider trading research around WAVE Life Sciences Ltd

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America